231. α1−アンチトリプシン欠乏症 Alpha-1-antitrypsin deficiency Clinical trials / Disease details


臨床試験数 : 93 薬物数 : 77 - (DrugBank : 8) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 36

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05727800
(ClinicalTrials.gov)
February 8, 20233/2/2023A Phase 1, First-in-human Study of VX-668A Phase 1, First-in-human Study of Safety, Tolerability, and Pharmacokinetics of VX-668Alpha-1 Antitrypsin DeficiencyDrug: VX-668;Drug: PlaceboVertex Pharmaceuticals IncorporatedNULLRecruiting18 Years55 YearsAll114Phase 1United States